Young and ambitious
GyneBio Pharma S.A. is a pharmaceutical company created in 2011 and located in Casablanca, Morocco.
We are a rapidly growing entity, with a diversified product portfolio that covers mainly the 3 therapeutic areas of Gynecology, Psychiatry and Analgesics.
We are considered as a major player in women's health, especially in Contraception thanks to our market leader position.
Our teams are coached by experienced Managers and developed through sharp HR processes and the highest demanding professional standards.
We have 3 poles of activity:
In order to market high added value products -of which Biotech. ones- we seek long-term alliances with partners that share our business beliefs. We also aim at making these products affordable to the largest number of patients.
We have an effective international dimension through Cooper Pharma group, allowing different partnerships building across these areas (in-licensing, products purchasing, dossiers development, production subcontracting for third parties) as well as Export sales development.
Quality drugs for family health
Our products are especially selected for their high therapeutic added value. They are based on renowned molecules with demonstrated medical service improvement.
We are mainly present in our “DNA” field of Gynecology, Psychiatry and Analgesics.
MICRODIOL® (Desogestrel + EE / Oral contraceptive), SAFORELLE® (Burdock / Soft cleaning care), GESTARELLE G® (Vitamin complex for Pregnancy), ActiGel®, FloraPlus®, Femipatch®
XAUTIS® (Olanzapine / Antipsychotic), ATHYMIL® (Mianserine / Antidepressant)
CARTREX® (Aceclofenac / Anti-inflammatory), RAVIVA® (Meloxicam / Anti-inflammatory), BIOFREEZE® (Menthol / Cold therapy)
Filtrum® (lignin 400 mg), O’MAG® (Magnesium therapy), FORTIA® (Vitamin complex), CALCIVIT® (Calcium, vit. D, magnesium), VITOP® (Vitamin complex, iron), INROS® (Alendronic Acid)
Our industrial flagship
In the 4th quarter of 2018, GyneBio Pharma launched its pioneer production site dedicated to hormonal drugs, located in Sapino industrial park, nearby Casablanca international airport.
This structuring project, 1st in Morocco and unique in North & West Africa, aims at answering local market needs for oral contraception as well as supplying International through Export.
It has been designed with compliance to current Good Manufacturing Practices and equipped with European tools and machines of the latest generation.
Apart from contraceptives, other hormonal products will also be manufactured, depending on the identified opportunities and developed partnerships.
Facility of 6 200 m² specialized in hormonal products manufacturing, in accordance with newest standards regarding drastic containment and HSE responsibility.
Capacity of 8 million units / year in 1 shift and up to 20 million in 3 shifts. This production capacity can be increased to reach 40 million units / year.
European (EMA) then US (FDA) certifications will be targeted from the beginning, as well as all relevant ISO ones.
Site built with close support from European experts. Managers with thorough pharmacy education and solid industry experience. Site operators trained on best quality standards.
Excellence and dedication
GyneBio Pharma is committed to offer a quality work environment to its people.
We believe that our employees are the most valuable asset for the company’s future. This is why we want them to consider GyneBio Pharma as the best environment to achieve professional and personal growth.
Because we aim at attracting, retaining and developing the best profiles, we have implemented a tailor-made integrated HR program that covers all the processes and tools needed for high standard people management.
In the walls, not only on the walls
Our ambition at GyneBio Pharma is to be recognized as a leading pharmaceutical company, thanks to our strong market position in our therapeutic areas as well as for the high quality of our products, people and services.
Relying on our teams professionalism, we want to build sound partnerships with the different health players for our patients interest.
Eight core values drive our business, each one of them being translated into observable behaviors to help embed our charter of conduct in routine company’s life and provide our Managers with a meaningful people management tool.
At individual's level
At team's level
At partner's & patient's level
At provider's level
We intend to recruit and develop talented candidates, to make them full members of GyneBio Pharma successful future. We believe that their contribution to company growth will result in their own development at professional career level.
We aim at providing our people with best learning environment, strongly encouraging performance, creativity, accountability and team spirit.
Mithra grants exclusive license to GyneBio Pharma for commercialization of its combined oral contraceptive Estelle® in Algeria, Morocco and Tunisia...Read More
GyneBio Pharma and the Korean pharmaceutical company Wooshin concluded an agreement aiming at marketing for a patch for the relief of menstrual cramps...Read More
GyneBio Pharma entered into an agreement with BioClin, a Dutch innovation company founded in 1989, in order to enable Moroccan women...Read More
GyneBio Pharma and the Indian pharmaceutical company Sanzyme Limited concluded an agreement aiming at marketing high level fertility products...Read More